Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

被引：90

作者：

Ganatra, Sarju ^{[1
,2
,5
]}

Redd, Robert ^{[3
]}

Hayek, Salim S. ^{[6
]}

Parikh, Rohan ^{[1
]}

Azam, Tariq ^{[6
]}

Yanik, Gregory A. ^{[7
]}

Spendley, Lauren ^{[4
]}

Nikiforow, Sarah ^{[4
]}

Jacobson, Caron ^{[4
]}

Nohria, Anju ^{[2
,5
]}

机构：

[1] Lahey Hosp & Med Ctr, Dept Med, Div Cardiovasc Med, Burlington, MA USA

[2] Dana Farber Canc Inst, Adult Canc Survivorship Program, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA

[5] Brigham & Womens Hosp, Div Cardiovasc Med, Cardiooncol Program, 75 Francis St, Boston, MA 02115 USA

[6] Univ Michigan, Div Cardiol, Ann Arbor, MI 48109 USA

[7] Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA

来源：

CIRCULATION | 2020年 / 142卷 / 17期

关键词：

axicabtagene ciloleucel; chimeric antigen receptor T-cell therapy; cardiomyopathy; cardiotoxicity; cytokine release syndrome; heart failure; lymphoma; non-Hodgkin; receptors; chimeric antigen; tisagenlecleucel;

D O I：

10.1161/CIRCULATIONAHA.120.048100

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1687 / 1690

页数：4

共 50 条

[1] Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects
Yu, Lingzi
Zou, Rui
He, Jiajie
Qu, Changju
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 199
[2] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Yin, Zixun
Zhang, Ya
Wang, Xin
BIOMARKER RESEARCH, 2021, 9 (01)
[3] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Zixun Yin
Ya Zhang
Xin Wang
Biomarker Research, 9
[4] Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies
Zhu, Feng
Wei, Guoqing
Zhang, Mingming
Zhao, Houli
Wu, Wenjun
Yang, Luxin
Hu, Yongxian
Huang, He
CELL TRANSPLANTATION, 2020, 29
[5] Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach
Saifi, Omran
Lester, Scott
Breen, William
Rule, William
Lin, Yi
Bennani, N. Nora
Rosenthal, Allison
Munoz, Javier
Murthy, Hemant
Kharfan-Dabaja, Mohamed
Peterson, Jennifer
Hoppe, Bradford
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (01) : 124 - 134
[6] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
Deshpande, Anagha
Rule, William
Rosenthal, Allison
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (01) : 89 - 98
[7] Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma
Hunter, Bradley D.
Chen, Yi-Bin
Jacobson, Caron A.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (04) : 687 - +
[8] Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
Korell, Felix
Schubert, Maria-Luisa
Sauer, Tim
Schmitt, Anita
Derigs, Patrick
Weber, Tim Frederik
Schnitzler, Paul
Mueller-Tidow, Carsten
Dreger, Peter
Schmitt, Michael
CANCERS, 2021, 13 (07)
[9] CAR T-Cell Therapy for Relapsed/Refractory Non-Hodgkin's Lymphoma: A Comprehensive Review
St-Pierre, Frederique
Gordon, Leo, I
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 309 - 318
[10] Establishing best practice in the Australian haematology setting for the use of chimeric antigen receptor T-cell therapy for relapsed and refractory lymphoma
Dickinson, Michael
O'Leary, Nicole
Hamad, Nada
Cochrane, Tara
Ho, P. Joy
Cheah, Chan Y.
Bishop, David
Gregory, Gareth P.
Butler, Jason
Barraclough, Allison
INTERNAL MEDICINE JOURNAL, 2025, 55 : 4 - 27

← 1 2 3 4 5 →